Establishing Safe Drainage Limits for Pleural Chest Tube Removal.

Thoracic Surgery Clinical Trial

Official title:

Defining the Threshold for Safe Chest Tube Removal.

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00574002
• Other study ID #: 07-68e
• Status: Withdrawn
• Phase: N/A
• First received: December 12, 2007
• Last updated: January 5, 2017
• Start date: December 2007
• Est. completion date: December 2009

Study information

• Verified date: January 2017
• Source: University of Missouri, Kansas City
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to evaluate a safe threshold for when to remove chest tubes in patients based on the amount of drainage present.

Description:

Measurement of pleural fluid drainage in chest tubes of trauma patients.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2009
• Est. primary completion date: November 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Presence of at least one chest tube

• No air leak present

• Fluid is not infected

• Pleural drainage of fluid was an indication for placement of the chest tube

• Patient is post-thoracic surgery

• Patient is post-thoracic trauma

• Informed consent obtained

Exclusion Criteria:

• Presence of air leak

• Infected pleural fluid

• Active intra-thoracic bleeding

• Thoracic empyema

• Non-removal of chest tube (i.e.: expired)

• Pregnancy

• Less than 18 years of age

• Unable to obtain informed consent

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Thoracic Surgery
• Thoracic Trauma

Locations

Country	Name	City	State
United States	Truman Medical Center	Kansas City	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
University of Missouri, Kansas City

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Repeat chest tube insertion within 30 days		two years	No
Primary	Thoracotomy on affected side within 30 days		Two years	No